Literature DB >> 31369251

Tandem Mass Spectrometric Quantification of 93 Terpenoids in Cannabis Using Static Headspace Injections.

Anna Shapira1, Paula Berman1, Kate Futoran1, Ohad Guberman1, David Meiri1.   

Abstract

The therapeutic effect of Cannabis largely depends on the content of its pharmacologically active secondary metabolites, mainly phytocannabinoids, flavonoids, and terpenoids. Recent studies suggest there are therapeutic effects of specific terpenoids as well as synergistic effects with other active compounds in the plant. Although Cannabis contains an overwhelming milieu of terpenoids, only a limited number are currently reported and used for metabolic analysis of Cannabis chemovars. In this study, we report the development and validation of a method for simultaneous quantification of 93 terpenoids in Cannabis air-dried inflorescences and extracts. This method employs the full evaporation technique via a static headspace sampler, followed by gas chromatography-mass spectrometry (SHS-GC/MS/MS). In the validation process, spiked terpenoids were quantified with acceptable repeatability, reproducibility, sensitivity, and accuracy. Three medical Cannabis chemovars were used to study the effect of sample preparation and extraction methods on terpenoid profiles. This method was further applied for studying the terpenoid profiles of 16 different chemovars acquired at different dates. Our results demonstrate that sample preparation methods may significantly impact the chemical fingerprint compared to the nontreated Cannabis. This emphasizes the importance of performing SHS extraction in order to study the natural terpenoid contents of chemovars. We also concluded that most inflorescences expressed relatively unique terpenoid profiles for the most pronounced terpenoids, even when sampled at different dates, although absolute concentrations may vary due to aging. The suggested method offers an ideal tool for terpenoid profiling of Cannabis and sets the scene for more comprehensive works in the future.

Entities:  

Year:  2019        PMID: 31369251     DOI: 10.1021/acs.analchem.9b02844

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  11 in total

1.  Nitrogen Source Matters: High NH4/NO3 Ratio Reduces Cannabinoids, Terpenoids, and Yield in Medical Cannabis.

Authors:  Avia Saloner; Nirit Bernstein
Journal:  Front Plant Sci       Date:  2022-06-01       Impact factor: 6.627

Review 2.  Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug.

Authors:  Shiri Procaccia; Gil Moshe Lewitus; Carni Lipson Feder; Anna Shapira; Paula Berman; David Meiri
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

Review 3.  Bridging the Accessibility Gap of Cannabinoid Medicine and Arabic Culture.

Authors:  Dror Robinson; Sivan Ritter; Lilach Zadik-Weiss; Hadile Ounallah-Saad; Nour Abu-Ahmad; Rashid Kashkoosh; Mustafa Yassin; Reuven Or
Journal:  Rambam Maimonides Med J       Date:  2020-01-30

4.  Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients.

Authors:  Jeffrey Y Hergenrather; Joshua Aviram; Yelena Vysotski; Salvatore Campisi-Pinto; Gil M Lewitus; David Meiri
Journal:  Rambam Maimonides Med J       Date:  2020-01-30

5.  Metabolic Profiling of Cannabis Secondary Metabolites for Evaluation of Optimal Postharvest Storage Conditions.

Authors:  Looz Milay; Paula Berman; Anna Shapira; Ohad Guberman; David Meiri
Journal:  Front Plant Sci       Date:  2020-10-15       Impact factor: 5.753

Review 6.  The Cannabis Terpenes.

Authors:  Sarana Rose Sommano; Chuda Chittasupho; Warintorn Ruksiriwanich; Pensak Jantrawut
Journal:  Molecules       Date:  2020-12-08       Impact factor: 4.411

Review 7.  The antimicrobial effect behind Cannabis sativa.

Authors:  Laureano Schofs; Mónica D Sparo; Sergio F Sánchez Bruni
Journal:  Pharmacol Res Perspect       Date:  2021-04

8.  Accelerated Solvent Extraction of Terpenes in Cannabis Coupled With Various Injection Techniques for GC-MS Analysis.

Authors:  Colton Myers; Jason S Herrington; Paul Hamrah; Kelsey Anderson
Journal:  Front Chem       Date:  2021-04-01       Impact factor: 5.221

9.  Sex differences in medical cannabis-related adverse effects.

Authors:  Joshua Aviram; Gil M Lewitus; Yelena Vysotski; Paula Berman; Anna Shapira; Shiri Procaccia; David Meiri
Journal:  Pain       Date:  2022-05-01       Impact factor: 6.961

10.  Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients.

Authors:  Joshua Aviram; Gil M Lewitus; Yelena Vysotski; Ben Yellin; Paula Berman; Anna Shapira; David Meiri
Journal:  Front Pharmacol       Date:  2021-05-19       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.